Showing results (91-100 of 619) with videos related to
Sort By:
Pageof 62
Kardiochirurgia I Torakochirurgia Polska = Polish Journal of Cardio-Thoracic Surgery|October 28, 2016
Diffuse coronary artery ectasia in a patient with left main coronary artery trifurcationJarosław Wasilewski, Piotr Desperak, Kamil Bujak, et al.Medicine|February 3, 2021
Survival rate after acute myocardial infarction in patients treated with percutaneous coronary intervention within the left main coronary artery according to time of admissionRafał Januszek, Kamil Bujak, Mariusz Gąsior, et al.Cardiology Journal|January 22, 2024
The characteristic of acute coronary syndromes of patients with multivessel coronary artery disease in centers with and without cardiac surgery on-siteKrzysztof Brust, Karol Śmiech, Kamil Bujak, et al.Kardiochirurgia I Torakochirurgia Polska = Polish Journal of Cardio-Thoracic Surgery|September 4, 2015
Risk factors for paravalvular leak after transcatheter aortic valve implantationKrzysztof Wilczek, Kamil Bujak, Rafał Reguła, et al.Kardiologia Polska|May 14, 2026
The very-long-term clinical outcomes following percutaneous coronary interventions for culprit lesions involving coronary bifurcations in patients with non-ST-segment elevation acute coronary syndromes: A propensity score matching analysisRadosław Liszka, Kamil Bujak, Michał Skrzypek, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of right coronary artery disease on mortality in patients undergoing percutaneous coronary intervention of unprotected left main coronary artery diseaseDavide Capodanno, Maria-Elena Di Salvo, Corrado TamburinoExpert Review of Cardiovascular Therapy|November 26, 2015
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face?Marco Barbanti, Simona Gulino, Corrado Tamburino, et al.Therapeutic Advances in Cardiovascular Disease|December 12, 2019
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical useDavide Capodanno, Rocco P Milluzzo, Dominick J AngiolilloFuture Cardiology|February 3, 2021
Canakinumab for secondary prevention of coronary artery diseaseLuis Ortega-Paz, Davide Capodanno, Dominick J AngiolilloJournal of Clinical Medicine|November 27, 2025
Intravascular Imaging Guidance for Percutaneous Coronary InterventionsMarco Spagnolo, Daniele Giacoppo, Antonio Greco, et al.Pageof 62